Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q2 2026 holdings

Shares (Q2 2026)
479,611
Value
$37.5M
% of portfolio
0.1%
Quarters held
21
Since Q1 2021
Holdings of HALO by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026479,611$37.5M0.1%−252,200−34.5%ReducedHolders
Q1 2026731,811$47.3M0.1%+169,100+30.1%AddedHolders
Q4 2025562,711$37.9M0.1%−437,498−43.7%ReducedHolders
Q3 20251,000,209$73.4M0.1%+661,600+195.4%AddedHolders
Q2 2025338,609$17.6M<0.1%+218,599+182.2%AddedHolders
Q1 2025120,010$7.66M<0.1%+93,900+359.6%AddedHolders
Q4 202426,110$1.25M<0.1%−229,170−89.8%ReducedHolders
Q3 2024255,280$14.6M<0.1%−122,300−32.4%ReducedHolders
Q2 2024377,580$19.8M<0.1%−53,800−12.5%ReducedHolders
Q1 2024431,380$17.5M<0.1%+238,000+123.1%AddedHolders
Q4 2023193,380$7.15M<0.1%+87,700+83.0%AddedHolders
Q3 2023105,680$4.04M<0.1%+71,600+210.1%AddedHolders
Q2 202334,080$1.23M<0.1%−61,061−64.2%ReducedHolders
Q1 202395,141$3.63M<0.1%−46,500−32.8%ReducedHolders
Q4 2022141,641$8.06M<0.1%−216,659−60.5%ReducedHolders
Q3 2022358,300$14.2M<0.1%−126,900−26.2%ReducedHolders
Q2 2022485,200$21.3M<0.1%+277,500+133.6%AddedHolders
Q1 2022207,700$8.28M<0.1%+81,700+64.8%AddedHolders
Q4 2021126,000$5.07M<0.1%−27,200−17.8%ReducedHolders
Q3 2021153,200$6.23M<0.1%+153,200NewHolders
Q2 20210$00.0%−673,700−100.0%Sold outHolders
Q1 2021673,700$28.1M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.